{"id":4404,"date":"2025-12-31T13:58:57","date_gmt":"2025-12-31T13:58:57","guid":{"rendered":"https:\/\/www.lifeviz.com\/publication\/behandlung-entstellender-kutaner-laesionen-bei-neurofibromatose-1-mit-everolimus-eine-offene-phase-ii-einarmstudie-drugs-in-rd-2018\/"},"modified":"2025-12-31T13:58:57","modified_gmt":"2025-12-31T13:58:57","slug":"behandlung-entstellender-kutaner-laesionen-bei-neurofibromatose-1-mit-everolimus-eine-offene-phase-ii-einarmstudie-drugs-in-rd-2018","status":"publish","type":"publication","link":"https:\/\/www.lifeviz.com\/de\/publication\/behandlung-entstellender-kutaner-laesionen-bei-neurofibromatose-1-mit-everolimus-eine-offene-phase-ii-einarmstudie-drugs-in-rd-2018\/","title":{"rendered":"Behandlung entstellender kutaner L\u00e4sionen bei Neurofibromatose\u20111 mit Everolimus: eine offene Phase\u2011II\u2011Einarmstudie \u2013 Drugs in R&D (2018)"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categoriepublication":[],"class_list":["post-4404","publication","type-publication","status-publish","hentry"],"acf":{"type":"","mise_en_avant":false,"lien":"https:\/\/link.springer.com\/article\/10.1007\/s40268-018-0248-6"},"_links":{"self":[{"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/publication\/4404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/media?parent=4404"}],"wp:term":[{"taxonomy":"categoriepublication","embeddable":true,"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/categoriepublication?post=4404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}